Membership
Tour
Register
Log in
Christopher J. Swank
Follow
Person
San Mateo, CA, US
People
Overview
Industries
Organizations
People
Information
Impact
Patents Grants
last 30 patents
Information
Patent Grant
SARS-COV2 main protease inhibitors
Patent number
12,091,420
Issue date
Sep 17, 2024
Gilead Sciences, Inc.
Stephen E. Ammann
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Thienopyrrole compounds
Patent number
11,661,431
Issue date
May 30, 2023
Gilead Sciences, Inc.
Stephen E. Ammann
C07 - ORGANIC CHEMISTRY
Patents Applications
last 30 patents
Information
Patent Application
SARS-COV2 MAIN PROTEASE INHIBITORS
Publication number
20240239807
Publication date
Jul 18, 2024
GILEAD SCIENCES, INC.
Stephen E. Ammann
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
SARS-COV2 MAIN PROTEASE INHIBITORS
Publication number
20240116946
Publication date
Apr 11, 2024
GILEAD SCIENCES, INC.
Stephen E. Ammann
C07 - ORGANIC CHEMISTRY
Information
Patent Application
THIENOPYRROLE COMPOUNDS
Publication number
20230365594
Publication date
Nov 16, 2023
GILEAD SCIENCES, INC.
Stephen E. Ammann
C07 - ORGANIC CHEMISTRY
Information
Patent Application
THIENOPYRROLE COMPOUNDS
Publication number
20220389034
Publication date
Dec 8, 2022
GILEAD SCIENCES, INC.
Stephen E. Ammann
C07 - ORGANIC CHEMISTRY